Ophteis
With Ophteis, Ophteis+ and OphteisMAX, Rayner offers a complete range of ophthalmic viscosurgical devices (OVD) made from hyaluronic acid of animal origin. The specific combination of different concentrations of HA and a high molecular weight has led to three distinct products with exemplary and complementary pseudoplastic qualities. The range manufactured in Sweden offers an optically clear OVD with no bubbles and can be stored at room temperature.
Ophteis
Cohesive – Designed for each stage of cataract surgery
- High molecular weight resulting in high viscosity and pseudoplasticity.
- High cohesion, meaning that it creates space, stabilizes the eye and facilitates movement of tissue.
- High pseudoplasticity enables easy and controlled injection and IOL implantation.
- Easy to remove as a single mass at the end of surgery.
Ophteis+
Highly Cohesive – Designed for difficult cases
- Super high molecular weight, pseudoplasticity and cohesion provides maximum intraocular stability, while creating space during capsulorhexis.
- Reliable in more difficult cases such as trauma and refractive surgery.
- Excellent performance during IOL implantation.
- Super high pseudoplasticity provides a product easy to inject and is removed as a single mass after surgery.
OphteisMAX
Visco-Adaptive – Designed to adapt to the different stages of surgery
- Viscoadaptive; at rest, it adopts cohesive characteristics (e.g. during capsulorhexis), and under stress it behaves in a dispersive way (e.g. during phacoemulsification).
- Excellent all round product that can also be used for advanced cases and trauma.
- Combines both high and low molecular weight hyaluronic acid.
- Easy to remove as a single mass at the end of surgery.
| Product Name | Ophteis |
| Model No. | B-OPH085
(0.85 ml syringe volume) |
| Contents | Sterile single use syringe with 0.85 ml 1.0% sodium hyaluronate solution and single-use 27 g injection cannula, Luer-Lock |
| Product Name | Ophteis+ |
| Model No. | B-OP+085 (0.85 ml syringe volume) |
| Contents | Sterile single use syringe with 0.85 ml 1.4% sodium hyaluronate solution and single-use 27 g injection cannula, Luer-Lock |
| Product Name | OphteisMAX |
| Model No. | B-OPX085
(0.85 ml syringe volume) |
| Contents | Sterile single use syringe with 0.85 ml 2.5% sodium hyaluronate solution and single-use 25 g injection cannula, Luer-Lock |
| Product | Ophteis | Ophteis+ | OphteisMAX |
| Polymer Origin | Animal origin | Animal origin | Animal origin |
| Sodium Hyaluronate Concentration | 1% | 1.40% | 2.50% |
| Molecular Weight (Dalton) | avg. 5 million | avg. 5 million | avg. 4 million |
| Zero Shear Viscosity (mPas) | avg. 1 million | avg. 3.3 million | avg. 1 million |
| Osmolality (mOsm/kg) | 310 | 320 | 360 |
| pH | 6.8 – 7.6 | 6.8 – 7.6 | 6.8 – 7.6 |
| Shelf Life (years) | 3 | 3 | 3 |
| Storage | 2 to 25 °C | 2 to 25 °C | 2 to 25 °C |
| Syringe Volume (ml) | 0.55 / 0.85 | 0.55 / 0.85 | 0.85 |
| Cannula Gauge (G) | 27 | 27 | 25 |
Not all products or offerings are approved or offered in every market and approved labelling and instructions may vary from one country to another. For country specific product information contact your local distributor or email iol_enquires@rayner.com.
This product is not approved by the FDA for use or distribution in the United States of America.
Rayner hold a selection of EC certificates for various products. Please contact the Regulatory Affairs team for the current version.
Request for more information
Feel free to request for a call back if you are interested in any of our listed products. Our friendly advisers are more than happy to answer any queries that you may have!
